Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2002
10/10/2002CA2443128A1 Transdermal delivery of pergolide
10/10/2002CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002CA2442827A1 "a method for the preparation of immunologically inert amniotic membranes"
10/10/2002CA2442798A1 Antioxidant nitroxides and nitrones as therapeutic agents
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002CA2442495A1 Alpha conotoxin peptides with analgesic properties
10/10/2002CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442370A1 Methods for increasing serotonin levels by administering (-)-hydroxycitric acid
10/10/2002CA2442354A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
10/10/2002CA2442330A1 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
10/10/2002CA2442150A1 Sapogenin derivatives, their synthesis and use, and methods based upon their use
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2441654A1 Cytoskeleton-associated proteins
10/10/2002CA2441252A1 Estrogen replacement therapy
10/10/2002CA2441077A1 Substituted carbazoles as inhibitors of spla2
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002CA2439842A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002CA2406832A1 Preventives/remedies for alzheimer's disease
10/09/2002EP1247809A2 Triazine compounds useful as sorbitol dehydrogenase inhibitors
10/09/2002EP1247533A2 Combination treatment of multiple sclerosis (MS), other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy
10/09/2002EP1246930A1 Replication incompetent herpes virus vectors
10/09/2002EP1246918A2 Secreted proteins
10/09/2002EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002EP1246843A1 Novel fgf homolog zfgf12
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002EP1246835A2 Substituted sapogenins and their use
10/09/2002EP1246827A1 New polymorphic forms of olanzapine
10/09/2002EP1246824A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246822A1 Benzofuran derivatives
10/09/2002EP1246821A2 Process for the preparation of paroxetine and synthetic intermeditates thereof
10/09/2002EP1246820A1 Novel heteroaryl derivatives, their preparation and use
10/09/2002EP1246818A1 Novel indole derivatives
10/09/2002EP1246817A1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
10/09/2002EP1246816A1 Substituted phenyl-piperazine derivatives, their preparation and use
10/09/2002EP1246815A1 Phenylpiperazinyl derivatives
10/09/2002EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246806A1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002EP1246805A1 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002EP1246799A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/09/2002EP1246797A1 Cyclopentyl sulfonamide derivatives
10/09/2002EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
10/09/2002EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002EP1246789A1 Racemic and optically pure metabolites of sibutramine, their preparation, compositions comprising them and their use as dopamine reuptake inhibitors
10/09/2002EP1246668A1 An rapid acting freeze dired oral pharmaceutical composition for treating migraine
10/09/2002EP1246632A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses
10/09/2002EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002EP1246629A1 Methods of using electron active compounds for managing cancer
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002EP1246624A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
10/09/2002EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002EP1246590A1 Local prevention or amelioration of pain from surgically closed wounds
10/09/2002EP1049467B1 Celecoxib compositions
10/09/2002EP1037874B1 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
10/09/2002EP0996622B1 Novel spiroazabicyclic heterocyclic compounds
10/09/2002EP0971714B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
10/09/2002EP0946542B1 Indane or dihydroindole derivatives
10/09/2002EP0910381A4 Method for treating pain
10/09/2002EP0754189B1 Receptor modulating agents and methods relating thereto
10/09/2002CN1373804A Conditional immortalisation of cells
10/09/2002CN1373774A Compositions isolated from skin cells and methods for their use
10/09/2002CN1373763A Pteridinones and kinase inhibitors
10/09/2002CN1373757A Heterocyclically substd, benzoylguanidine, method for production thereof, use thereof as medicament or means of diagnosis and medicaments contg. same
10/09/2002CN1373752A Prostaglandin derivs.
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/09/2002CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002CN1373660A Method for treating chronic pain using MEK inhibitors
10/09/2002CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
10/09/2002CN1372969A Medical liquor for treating rheuamtic arthritis ischias, etc
10/09/2002CN1372958A Prescription of liquid medicine for invigorating function of stomach, protecting liver and sobering up
10/09/2002CN1372952A Cigarette for dropping drug and its addition and building body up and its preparing process
10/09/2002CN1372948A Exterior-applied liquid medicine for promoting blood circulation, dispelling exogenous factor of wind and relaxing pain
10/09/2002CN1372805A Tea for refreshing and sobering up and its preparing process
10/09/2002CN1092202C Substd. aminoalkane phosphonic acids
10/09/2002CN1092193C Prolylendopeptidase inhibitors
10/09/2002CN1092192C Pyrrolyl tetrahydroquinoxalin diones, their production and use in treatment of diseases
10/09/2002CN1092062C Chinese medicine for treating vascular headache
10/08/2002US6462222 Aminoindan derivatives
10/08/2002US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia,
10/08/2002US6462171 Inhibitory peptide for alzheimer*s and prion encephalopathy disease treatment
10/08/2002US6462089 Modafinil; restoring a normal sleep pattern; myotonic dystrophy
10/08/2002US6462086 Non-malignant disease treatment with Ras antagonists
10/08/2002US6462084 Gamma vinyl gamma amino butyric acid; prolonged effect; irreversible enzyme inhibitor that raises endogenous levels without addiction
10/08/2002US6462078 Antiinflammatory agents; library of plant extracts
10/08/2002US6462074 Substituted α, β-anellated butyrolactones
10/08/2002US6462072 Such as 4,4-diphenylcyclohexl-1-(3,3-dimethyl-2-oxopentan-oyl)-pyrrolidine-2 -carboxylate; rotamase inhibitors; neuronal repair and regrowth; parkinson's disease, alzheimer's disease, amyotrophic lateral sclerosis
10/08/2002US6462068 Heterocyclylmethyl-substituted pyrazole derivatives
10/08/2002US6462067 Administering histamine or salt derivative; preventing and/or reducing oxidative cellular and tissue damage; inflammatory diseases, including rheumatoid arthritis, crohn's disease, and adult respiratory distress syndrome
1 ... 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 ... 1833